Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of genetic testing in prostate cancer screening, diagnosis, and treatment.

Current opinion in oncology - 1 May 2022

de la Calle Claire M, Bhanji Yasin, Pavlovich Christian P, Isaacs William B

Abstract excerpt

PURPOSE OF REVIEW: This review provides an overview of the current role of genetic testing in prostate cancer screening, diagnosis, and treatment. RECENT FINDINGS: Recent studies have uncovered few but highly penetrant rare pathogenic mutations (RPMs), in genes, such as BRCA2, with strong prostate cancer risk and outcomes associations. Over 260 single nucleotide polymorphisms (SNPs) have also been identified,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Genes, BRCA2
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 35238838
DOI: 10.1097/CCO.0000000000000823

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of genetic testing in prostate cancer screening, diagnosis, and treatment.PMID 35238838Read ↗

Genetics and Screening in Prostate Cancer.Semantic proximity Read ↗

Genetic testing in prostate cancer management: Considerations informing primary care.Semantic proximity Read ↗

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease ManagementSemantic proximity Read ↗

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testingSemantic proximity Read ↗

Genetics of prostate cancer and its utility in treatment and screening.Semantic proximity Read ↗

Genetic testing for hereditary prostate cancer: Current status and limitations.Semantic proximity Read ↗

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing GuidelinesSemantic proximity Read ↗

Genetic testing for the clinician in prostate cancer.Semantic proximity Read ↗

Recent Insights on Genetic Testing in Primary Prostate Cancer.Semantic proximity Read ↗

Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testingSemantic proximity Read ↗

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowSemantic proximity Read ↗

Overview of Prostate Cancer Genetic Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.